Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Forte Biosciences, Inc. (FBRX)
Market Closed
17 Jul, 20:00
NASDAQ (CM)
All
(4)
DE
(3)
US
(1)
NASDAQ (CM)
Primary
XMUN
XFRA
XSTU
$
48.
86
+3.87
+8.6019%
$
609.86M
Market Cap
-
P/E Ratio
-
Div Yield
595,800
Volume
-
Eps
$
44.99
Previous Close
Investors:
NCG
Watching
Watch
Add Transaction
Day Range
42
50
Year Range
9.1
50
Want to track
FBRX
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
News
Historical Data
Investors
Forte Biosciences, Inc. (FBRX) Statistics
Valuation metrics
Market Cap
609.86M
Enterprise value
620.23M
Trailing P/E (ttm)
-10.67
Forward P/E
-7.14
PEG ratio
-0.11
Price/Sales (ttm)
-
Price/Book (mrq)
207.02
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
-8.34
Overview
Shares outstanding
12.95M
Float
17.32M
Shares short
892.18K
% Held by insiders
0.02%
% Held by institutions
0.67%
Average volume (10 days)
595.67K
Average volume (90 days)
337.01K
Price summary
52-Week low
9.1
52-Week high
50
Beta
3.2
50-Day moving average
23.17
200-Day moving average
27.76
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:25
Last split Date
28 Aug 2024
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
-
Operating margin
-
Operational effectiveness
Return on assets
-1.13%
Return on equity
-1.06%
Income Statement
Revenue (ttm)
-
Revenue per share (ttm)
-
Quarterly revenue growth (yoy)
-
Gross profit (ttm)
-
EBITDA
-70.59M
Net income to common (ttm)
-69.38M
Diluted EPS (ttm)
-0.43
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
76.96M
Total cash per share (mrq)
0.33
Total debt (mrq)
-
Total Debt/Equity (mrq)
-
Current ratio (mrq)
2.75%
Book value per share (mrq)
0.24
Cash Flow
Cash flow statement
-50.88M
Levered free cash flow (LFCF)
-26.94M